BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34196986)

  • 1. Focal cortical dysplasia type 1.
    Coras R; Holthausen H; Sarnat HB
    Brain Pathol; 2021 Jul; 31(4):e12964. PubMed ID: 34196986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission.
    Najm I; Lal D; Alonso Vanegas M; Cendes F; Lopes-Cendes I; Palmini A; Paglioli E; Sarnat HB; Walsh CA; Wiebe S; Aronica E; Baulac S; Coras R; Kobow K; Cross JH; Garbelli R; Holthausen H; Rössler K; Thom M; El-Osta A; Lee JH; Miyata H; Guerrini R; Piao YS; Zhou D; Blümcke I
    Epilepsia; 2022 Aug; 63(8):1899-1919. PubMed ID: 35706131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: The international consensus classification of Focal Cortical Dysplasia - a critical update 2018.
    Najm IM; Sarnat HB; Blümcke I
    Neuropathol Appl Neurobiol; 2018 Feb; 44(1):18-31. PubMed ID: 29359399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological work-up of focal cortical dysplasias using the new ILAE consensus classification system - practical guideline article invited by the Euro-CNS Research Committee.
    Blümcke I; Mühlebner A
    Clin Neuropathol; 2011; 30(4):164-77. PubMed ID: 21726501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variable histopathology features of neuronal dyslamination in the cerebral neocortex adjacent to epilepsy-associated vascular malformations suggest complex pathogenesis of focal cortical dysplasia ILAE type IIIc.
    Miyata H; Kuwashige H; Hori T; Kubota Y; Pieper T; Coras R; Blümcke I; Yoshida Y
    Brain Pathol; 2022 Sep; 32(5):e13052. PubMed ID: 35001442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
    Zimmer TS; Broekaart DWM; Luinenburg M; Mijnsbergen C; Anink JJ; Sim NS; Michailidou I; Jansen FE; van Rijen PC; Lee JH; François L; van Eyll J; Dedeurwaerdere S; van Vliet EA; Mühlebner A; Mills JD; Aronica E
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A distinct clinicopathological variant of focal cortical dysplasia IIId characterized by loss of layer 4 in the occipital lobe in 12 children with remote hypoxic-ischemic injury.
    Wang DD; Piao YS; Blumcke I; Coras R; Zhou WJ; Gui QP; Liu CC; Hu JX; Cao LZ; Zhang GJ; Lu DH
    Epilepsia; 2017 Oct; 58(10):1697-1705. PubMed ID: 28833053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunohistochemical characteristics of type II and type I focal cortical dysplasia.
    Yao K; Duan Z; Zhou J; Li L; Zhai F; Dong Y; Wang X; Ma Z; Bian Y; Qi X; Li L
    Oncotarget; 2016 Nov; 7(47):76415-76422. PubMed ID: 27811355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread frontal lobe cortical dysplasia or partial hemimegalencephaly: a continuum of the spectrum.
    Cvetkovska E; Kuzmanovski I; Boskovski B; Babunovska M; Trencevska KG
    Epileptic Disord; 2019 Oct; 21(5):471-474. PubMed ID: 31617492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis.
    Kapar O; Gurkan ZM; Dolgun M; Sencer A; Gürses C; Bilgic B
    Neurosurg Focus; 2022 Oct; 53(4):E6. PubMed ID: 36183176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive clinico-pathological and genetic evaluation of bottom-of-sulcus focal cortical dysplasia in patients with difficult-to-localize focal epilepsy.
    Ying Z; Wang I; Blümcke I; Bulacio J; Alexopoulos A; Jehi L; Bingaman W; Gonzalez-Martinez J; Kobow K; Niestroj LM; Lal D; Koelble K; Najm I
    Epileptic Disord; 2019 Feb; 21(1):65-77. PubMed ID: 30782578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of 92 patients with temporal lobe focal cortical dysplasia identified by pathological examination.
    Wu J; Li W; Chen Y; Kang L; Zhao W
    J Clin Neurosci; 2014 Dec; 21(12):2170-4. PubMed ID: 25065846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward a refined genotype-phenotype classification scheme for the international consensus classification of Focal Cortical Dysplasia.
    Blumcke I; Cendes F; Miyata H; Thom M; Aronica E; Najm I
    Brain Pathol; 2021 Jul; 31(4):e12956. PubMed ID: 34196989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal cortical dysplasias in temporal lobe epilepsy surgery: Challenge in defining unusual variants according to the last ILAE classification.
    Martinoni M; Marucci G; Rubboli G; Volpi L; Riguzzi P; Marliani F; Toni F; Naldi I; Bisulli F; Tinuper P; Michelucci R; Baruzzi A; Giulioni M
    Epilepsy Behav; 2015 Apr; 45():212-6. PubMed ID: 25812941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specific DNA methylation landscape in focal cortical dysplasia ILAE type 3D.
    Wang DD; Katoch M; Jabari S; Blumcke I; Blumenthal DB; Lu DH; Coras R; Wang YJ; Shi J; Zhou WJ; Kobow K; Piao YS
    Acta Neuropathol Commun; 2023 Aug; 11(1):129. PubMed ID: 37559109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative ultrasonography (ioUS) characteristics of focal cortical dysplasia (FCD) type II b.
    Prada F; Gennari AG; Del Bene M; Bono BC; Quaia E; D'Incerti L; Villani F; Didato G; Tringali G; DiMeco F
    Seizure; 2019 Jul; 69():80-86. PubMed ID: 30999253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corpora amylacea in the neocortex in patients with temporal lobe epilepsy and focal cortical dysplasia.
    Estupiñán-Díaz BO; Morales-Chacón LM; García-Maeso I; Lorigados-Pedre L; Báez-Martín M; García-Navarro ME; Trápaga-Quincoses O; Quintanal-Cordero N; Prince-López J; Bender-del Busto JE;
    Neurologia; 2015 Mar; 30(2):90-6. PubMed ID: 25440067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putting the new ILAE classification of focal cortical dysplasia into practice in western China.
    Huang C; Zhang H; Chi XS; Chen N; Gong J; Zhou Q; Blümcke I; Zhou D; Li JM
    Seizure; 2017 Oct; 51():133-138. PubMed ID: 28843774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission.
    Blümcke I; Thom M; Aronica E; Armstrong DD; Vinters HV; Palmini A; Jacques TS; Avanzini G; Barkovich AJ; Battaglia G; Becker A; Cepeda C; Cendes F; Colombo N; Crino P; Cross JH; Delalande O; Dubeau F; Duncan J; Guerrini R; Kahane P; Mathern G; Najm I; Ozkara C; Raybaud C; Represa A; Roper SN; Salamon N; Schulze-Bonhage A; Tassi L; Vezzani A; Spreafico R
    Epilepsia; 2011 Jan; 52(1):158-74. PubMed ID: 21219302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathologic measurements in focal cortical dysplasias: validation of the ILAE 2011 classification system and diagnostic implications for MRI.
    Mühlebner A; Coras R; Kobow K; Feucht M; Czech T; Stefan H; Weigel D; Buchfelder M; Holthausen H; Pieper T; Kudernatsch M; Blümcke I
    Acta Neuropathol; 2012 Feb; 123(2):259-72. PubMed ID: 22120580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.